ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver cirrhosis"

  • 2022 American Transplant Congress

    Liver Transplantation is Beneficial Regardless of Cirrhosis Stage or Acute-on-Chronic Liver Failure Grade: A Single-Center Experience

    E. Cervantes-Alvarez, O. Mendez-Guerrero, D. Kershenobich, A. Torre, M. Vilatobá, N. Navarro-Alvarez

    Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

    *Purpose: Liver transplantation for the most critically ill remains controversial; however, it is currently the only curative treatment option. The aim of this study was…
  • 2022 American Transplant Congress

    Molecular Characterization of Progressive Fibrosis in the Liver by Single-Nuclei RNA Sequencing

    T. Rousselle1, J. McDaniels1, A. Shetty1, E. Bardhi1, D. Polsky1, E. Williams1, D. Maluf2, V. Mas1

    1Surgical Sciences, University of Maryland Baltimore, Baltimore, MD, 2Transplantation Program, University of Maryland Medical Center, Baltimore, MD

    *Purpose: The prevalence of obesity is negatively affecting the availability of livers for transplantation. Non-alcoholic fatty liver disease (NAFLD) is associated with an increase in…
  • 2021 American Transplant Congress

    A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation

    F. M. Nimri1, S. Naffouj1, F. Askar1, A. Singh2, H. Gonzalez2, S. Jafri2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Gastroenterology, Henry Ford Hospital, Detroit, MI

    *Purpose: Phosphatidylethanol (PEth) is a phospholipid that forms in the presence of ethanol with a long half-life compared to other alcohol detection tests. PEth testing…
  • 2021 American Transplant Congress

    The Rate of Hospitalization Among Patients with Cirrhosis is More Than Twice as High as Patients Over 85 Years

    N. R. Mazumder1, K. Guo2, L. Zhao3, A. Kho1, K. Walters4, T. S. Carey4, C. Loftus1, D. P. Ladner1

    1Northwestern Memorial Hospital, Chicago, IL, 2Biostatistics, Northwestern Memorial Hospital, Chicago, IL, 3Biostatistcs, Northwestern Memorial Hospital, Chicago, IL, 4University of North Carolina Chapel Hill, Chapel Hill, NC

    *Purpose: Cirrhosis is a common disease however it is understudied because population data on patients with cirrhosis is lacking. While the risk of hospitalization in…
  • 2021 American Transplant Congress

    The Role of Histone Acetylation/methylation Mediated Epigenetic Modifications in the Pathogenesis of Non-alcoholic Steatohepatitis-associated Liver Carcinogenesis

    P. K. Rajan1, U. Utibe-Abasi1, J. D. Sanabria1, M. Banerjee2, G. Smith1, M. S. Schade1, J. Sanabria1, K. Sodhi1, S. Pierre2, Z. Xie2, J. I. Shapiro2, J. Sanabria1

    1Department of Surgery, Marshall University, Huntington, WV, 2Marshall Institute for Interdisciplinary Research (MIIR), Marshall University, Huntington, WV

    *Purpose: Hepatocellular carcinoma (HCC) is one of the most aggressive human cancers and is characterized by an acquisition of multiple abnormal phenotypes driven by epigenetic…
  • 2021 American Transplant Congress

    Outcomes of Transjugular Intrahepatic Portosystemic Shunts (TIPS) in Dialysis-Dependent ESLD Patients: The ALTA Study

    J. Ge1, J. Boike2, M. German3, G. J. Morelli4, E. Spengler3, A. Said3, A. S. Lee3, A. Hristov3, A. Desai5, T. Couri6, S. Paul6, C. Frenette7, N. Christian-Miller7, M. Laurito8, E. Verna8, U. Rahim9, A. Goel9, D. Gregory2, L. VanWagner2, K. P. Kolli1, J. Lai1

    1University of California, San Francisco, San Francisco, CA, 2Northwestern Memorial Hospital, Chicago, IL, 3University of Wisconsin, Madison, WI, 4University of Florida Health, Gainsville, FL, 5Indiana University School of Medicine, Indianapolis, IN, 6University of Chicago, Chicago, IL, 7The Scripps Clinic, La Jolla, CA, 8Columbia University, New York, NY, 9Stanford University, Stanford, CA

    *Purpose: Data on the outcomes of patients with cirrhosis who require renal replacement therapy (RRT) at the time of transjugular intrahepatic portosystemic shunts (TIPS) is…
  • 2021 American Transplant Congress

    Home-based Liver Frailty Intervention (lift) in Liver Transplant Candidates: A Pilot Study

    A. J. Thuluvath1, K. Belfanti1, S. Morrissey1, O. Siddiqui1, J. Peipert1, A. Daud1, J. Levitsky1, T. Bogg2, A. Flores1, D. P. Ladner1

    1Northwestern University Transplant Research Collaborative, Chicago, IL, 2Department of Psychology, Wayne State University, Detroit, MI

    *Purpose: Frailty is highly prevalent in patients awaiting LT and is associated with increased waitlist and post-transplant mortality, hospitalizations and LOS. While reduction of frailty…
  • 2021 American Transplant Congress

    Kidney Transplantation Alone in Patients with Compensated Cirrhosis: A Multicenter Study

    A. Kassem1, S. Asrani1, S. W. Biggins2, Y. Darwish1, M. Nadim3, B. Fischbach1, T. Fong3

    1Baylor University Medical Center at Dallas, Dallas, TX, 2University of Washington, Seattle, WA, 3USC - Keck, Los Angeles, CA

    *Purpose: Patients undergoing kidney transplant (KTA) often have risk factors for liver disease including viral hepatitis and non-alcoholic fatty liver disease (NAFLD). Recent European Association…
  • 2021 American Transplant Congress

    Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome

    J. Doi, M. Fujiki, G. DAmico, K. Sasaki, T. Diago, F. Aucejo, C. Kwon, B. Eghtesad, K. Hashimoto, C. Miller, Q. Cristiano

    Cleveland Clinic, Cleveland, OH

    *Purpose: Hepato-pulmonary syndrome (HPS) is a complication of liver disease with liver transplantation as the only curative treatment. However these patients can develop severe hypoxemia…
  • 2021 American Transplant Congress

    Assessing the Prevalence of Risk Factors for Osteoporosis and Rate of Screening by Dexa Scan in Patients Referred for Liver Transplant Evaluation

    A. France1, J. Kirk2, M. Dokus2, B. Al-Judaibi2, M. Laryea2

    1Department of Internal Medicine, University of Rochester Medical Center, Rochester, NY, 2Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, NY

    *Purpose: Osteoporosis (OP) and fragility fractures are well-known complications of both chronic liver disease (CLD) and transplant, with a significant increase in the prevalence of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences